Successful Management of Malignant Pericarditis Using Nivolumab for Metastatic Esophageal Squamous Cell Carcinoma

被引：0
|
作者：
Uneno, Yu [1 ]
Nomura, Motoo [1 ]
Hosokai, Taisuke [1 ]
Kurakake, Yoshinosuke [1 ]
Fuki, Masayuki [1 ]
Shiomi, Hiroki [2 ]
Takeuchi, Yasuhide [3 ]
Tamaoki, Masashi [1 ]
Yokoyama, Akira [1 ]
Katada, Chikatoshi [1 ]
Muto, Manabu [1 ]
机构：
[1] Kyoto Univ Hosp, Dept Clin Oncol, Kyoto, Japan
[2] Kyoto Univ Hosp, Dept Cardiovasc Med, Kyoto, Japan
[3] Kyoto Univ Hosp, Dept Diagnost Pathol, Kyoto, Japan
来源：
INTERNAL MEDICINE | 2024年 / 63卷 / 05期
关键词：
esophageal cancer; nivolumab; cardiac tamponade; pericarditis; pericardial effusion; pericardial drainage; CARDIAC-TAMPONADE; EFFUSION; CANCER; PERICARDIOCENTESIS; EXPRESSION; CISPLATIN; TUMORS; TRIAL;
D O I：
10.2169/internalmedicine.2041-23
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Esophageal cancer is a malignant disease with a poor prognosis and is one of the most common causes of cardiac metastasis. Malignant pericarditis may cause the repetitive accumulation of pericardial effusion, which can occasionally pose a clinical challenge. We herein report a case of malignant pericarditis in a patient with metastatic esophageal squamous cell carcinoma with cardiac tamponade, which was successfully managed with single pericardial drainage and systemic nivolumab monotherapy. This is the first case report to suggest that systemic therapy with nivolumab is a promising option for the management of malignant pericarditis.
引用
收藏
页码：677 / 680
页数：4
相关论文
共 50 条
  • [31] TET2 Is Downregulated in Early Esophageal Squamous Cell Carcinoma and Promotes Esophageal Squamous Cell Malignant Behaviors
    Wen, Hui
    Liu, Xiao-bo
    Zhu, Zhao-di
    Jin, Shu
    Gao, Yuan-jun
    Tong, Qiang
    Li, Sheng-bao
    DIGESTIVE DISEASES AND SCIENCES, 2024, 69 (07) : 2462 - 2476
  • [32] The relationship between treatment-induced hypertension and efficacy of anlotinib in recurrent or metastatic esophageal squamous cell carcinoma
    Song, Yan
    Xiao, Juxiang
    Fang, Wentao
    Lu, Ping
    Fan, Qingxia
    Shu, Yongqian
    Feng, Jifeng
    Zhang, Shu
    Ba, Yi
    Zhao, Yang
    Liu, Ying
    Bai, Chunmei
    Bai, Yuxian
    Tang, Yong
    He, Jie
    Huang, Jing
    CANCER BIOLOGY & MEDICINE, 2021, 18 (02) : 562 - +
  • [33] A phase 2 study of first-line nivolumab in patients with locally advanced or metastatic cutaneous squamous-cell carcinoma
    Munhoz, Rodrigo R.
    Nader-Marta, Guilherme
    de Camargo, Veridiana P.
    Queiroz, Marcello M.
    Cury-Martins, Jade
    Ricci, Herminia
    de Mattos, Marcela R.
    de Menezes, Thiago A. F.
    Machado, Guilherme U. C.
    Bertolli, Eduardo
    Barros, Milton
    de Souza, Carina E.
    Franke, Fabio
    Ferreira, Fabio O.
    Feher, Olavo
    de Castro Jr, Gilberto
    CANCER, 2022, 128 (24) : 4223 - 4231
  • [34] Clinical outcome of nivolumab in older and frail patients with recurrent/metastatic head and neck squamous cell carcinoma
    Becherini, Carlotta
    Banini, Marco
    Desideri, Isacco
    Salvestrini, Viola
    Caprara, Luisa
    Scotti, Vieri
    Ganovelli, Michele
    Morelli, Ilaria
    Romei, Andrea
    Livi, Lorenzo
    Bonomo, Pierluigi
    JOURNAL OF GERIATRIC ONCOLOGY, 2023, 14 (01)
  • [35] Association of autoimmunity with survival in patients with recurrent/metastatic head and neck squamous cell carcinoma treated with nivolumab
    Economopoulou, Panagiota
    Kotsantis, Ioannis
    Papaxoinis, George
    Gavrielatou, Niki
    Anastasiou, Maria
    Pantazopoulos, Anastasios
    Kavourakis, George
    Gkolfinopoulos, Stavros
    Panayiotides, Ioannis
    Delides, Alexandros
    Psyrri, Amanda
    ORAL ONCOLOGY, 2020, 111
  • [36] Inflammatory prognostic factors in advanced or recurrent esophageal squamous cell carcinoma treated with nivolumab
    Tatsuki Ikoma
    Mototsugu Shimokawa
    Toshihiko Matsumoto
    Shogen Boku
    Tomoyo Yasuda
    Nobuhiro Shibata
    Yusuke Kurioka
    Masahiro Takatani
    Tetsuji Nobuhisa
    Tsutomu Namikawa
    Hiroyuki Kitagawa
    Kazuhiro Hanazaki
    Keitaro Doi
    Takanobu Shimada
    Takehiko Tsumura
    Hiroyuki Marusawa
    Seichiro Kanaya
    Shuko Morita
    Tetsurou Inokuma
    Hiroki Nagai
    Hisateru Yasui
    Hironaga Satake
    Cancer Immunology, Immunotherapy, 2023, 72 : 427 - 435
  • [37] Watermelon stomach, hemorrhagic pericarditis, small cell carcinoma of the lung and synchronous squamous cell carcinoma of the tongue base
    Murinello, A.
    Damasio, H.
    Figueiredo, A. M.
    Netta, J.
    Carvalho, A.
    Matos, A. A.
    Murillo, M. J.
    Albuquerque, A.
    REVISTA PORTUGUESA DE PNEUMOLOGIA, 2010, 16 (04) : 659 - 670
  • [38] Profile of Nivolumab in the Treatment of Resected Esophageal Squamous Cell Carcinoma: A Review of the Clinical Data
    Kim, Yuntae
    Yamamoto, Shun
    Kato, Ken
    CANCER MANAGEMENT AND RESEARCH, 2023, 15 : 399 - 406
  • [39] Identification of serum microRNAs predicting the response of esophageal squamous-cell carcinoma to nivolumab
    Sudo, Kazuki
    Kato, Ken
    Matsuzaki, Juntaro
    Takizawa, Satoko
    Aoki, Yoshiaki
    Shoji, Hirokazu
    Iwasa, Satoru
    Honma, Yoshitaka
    Takashima, Atsuo
    Sakamoto, Hiromi
    Naka, Tomoaki
    Sekine, Shigeki
    Boku, Narikazu
    Ochiya, Takahiro
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2020, 50 (02) : 114 - 121
  • [40] A case report of metastatic esophageal squamous cell carcinoma during pregnancy
    Shaikh, Bisma
    Alam, Muhammad Taha
    Samad, Shahzaib
    Danishwar, Mahmood
    SAGE OPEN MEDICAL CASE REPORTS, 2024, 12
12345